Hematological cancer in 2011: New therapeutic targets and treatment strategies. - Wikidata - awgldk - TriplyDB

Hematological cancer in 2011: New therapeutic targets and treatment strategies.

Hematological cancer in 2011: New therapeutic targets and treatment strategies.

http://www.wikidata.org/entity/Q37974569

about

CD19-redirected chimeric antigen receptor-modified T cells: a promising immunotherapy for children and adults with B-cell acute lymphoblastic leukemia (ALL)Investigative and clinical applications of synthetic immune synapses Mechanisms of epigenetic regulation of leukemia onset and progression Failure of anti tumor-derived endothelial cell immunotherapy depends on augmentation of tumor hypoxia.A good manufacturing practice method to ex vivo expand natural killer cells for clinical use.MLN2238, a proteasome inhibitor, induces caspase-dependent cell death, cell cycle arrest, and potentiates the cytotoxic activity of chemotherapy agents in rituximab-chemotherapy-sensitive or rituximab-chemotherapy-resistant B-cell lymphoma preclinic Perifosine and sorafenib combination induces mitochondrial cell death and antitumor effects in NOD/SCID mice with Hodgkin lymphoma cell line xenografts.Pain Phenotypes and Associated Clinical Risk Factors Following Traumatic Amputation: Results from Veterans Integrated Pain Evaluation Research (VIPER).Perceived need for information among patients with a haematological malignancy: associations with information satisfaction and treatment decision-making preferences.

P2860

Q26783433-42DAA5F5-F91E-47B5-BFD2-282E6C4ADF4B Q26825315-32982220-3CA7-43A1-8226-863D462BD331 Q26861785-DB908581-6BDD-4859-8C43-38A793EC50E0 Q34786452-2D9B773A-5C13-4095-A0B4-3556CE270036 Q36187369-5ADABB44-401F-4AB0-A01B-3E7B76BA49D9 Q39101546-70E28E83-B828-4783-8639-13A7FB48E669 Q39202496-7BAAD3F9-944B-4EF2-B4F7-B18D70B82163 Q45328060-96CC981C-E86A-45A7-8C34-24E79DEB22BB Q48077006-E3B9A023-8021-405F-B1F3-2A745DC19AEE

P2860

Hematological cancer in 2011: New therapeutic targets and treatment strategies.

http://www.wikidata.org/entity/Q37974569

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Hematological cancer in 2011: New therapeutic targets and treatment strategies.

@en

Hematological cancer in 2011: New therapeutic targets and treatment strategies.

@nl

type

label

Hematological cancer in 2011: New therapeutic targets and treatment strategies.

@en

Hematological cancer in 2011: New therapeutic targets and treatment strategies.

@nl

prefLabel

Hematological cancer in 2011: New therapeutic targets and treatment strategies.

@en

Hematological cancer in 2011: New therapeutic targets and treatment strategies.

@nl

P1433

Q37974569-221FEB98-067A-4AD3-88C6-E199466417FE

P1476

Q37974569-06E4C697-B90F-48DC-8530-ECDB4C3065E2

P2093

Q37974569-179CF267-5E14-44F8-8409-DC16D169C52F

P2860

Q37974569-53527D6D-D099-44E9-A75B-A12C77DD99C9

Q37974569-5731B0DE-A5F6-473C-9FC2-B77C5A4139BE

Q37974569-6B456C9B-EC27-4261-8F46-2F3DF0C63E85

Q37974569-77CD8FD0-42A7-48F7-8BC0-0029FDD080C0

Q37974569-7A21AA95-C81F-43D9-87C5-B00459CBEB85

Q37974569-9182E40F-E132-4329-987F-5EEC4E201F06

Q37974569-B7ADE938-B5B9-4B38-AAA4-469608ABC018

Q37974569-BBE5BC12-5ABE-4867-AA05-EDAFEA5638CE

P2888

Q37974569-47A58679-45CD-463E-BD56-1EFF214A94C3

P304

Q37974569-4EF815FA-8B00-4979-B620-74AA141007D5

P31

Q37974569-7A765F9C-AEEB-4B19-8B9F-9B08A9647915

P356

Q37974569-9BBA1872-D29A-45D4-A969-6AF5A0D02AB8

P407

Q37974569-21F5237A-467D-4CF9-A956-02ECD4D68B31

P433

Q37974569-2AF4D4EC-E284-485F-9409-6A1E118A58AE

P478

Q37974569-481E5E12-461D-4228-A607-49AFE0746D7E

P50

Q37974569-40DC2D17-C209-4557-B87D-0A6992FFBFAF

P577

Q37974569-194CBC43-4580-4B50-BD49-B595A9363A19

P6179

Q37974569-1A87FE9A-11F5-4DC2-9DF3-3D04BE46A243

P698

Q37974569-364077CA-C60D-4A50-9758-997F44BC2BDB

P356

NRCLINONC.2011.212

P1433

Nature Reviews Clinical Oncology

P1476

Hematological cancer in 2011: New therapeutic targets and treatment strategies.

@en

P2093

Paula Cramer

http://www.w3.org/2001/XMLSchema#string

P2860

Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia

Bortezomib plus CHOP-rituximab for previously untreated diffuse large B-cell lymphoma and mantle cell lymphoma.

Rituximab maintenance for 2 years in patients with high tumour burden follicular lymphoma responding to rituximab plus chemotherapy (PRIMA): a phase 3, randomised controlled trial.

ABVD versus BEACOPP for Hodgkin's lymphoma when high-dose salvage is planned.

Self-renewing hematopoietic stem cell is the primary target in pathogenesis of human chronic lymphocytic leukemia.

Reduced treatment intensity in patients with early-stage Hodgkin's lymphoma.

Eight cycles of escalated-dose BEACOPP compared with four cycles of escalated-dose BEACOPP followed by four cycles of baseline-dose BEACOPP with or without radiotherapy in patients with advanced-stage hodgkin's lymphoma: final analysis of the HD12 t

Long-term follow-up of patients with newly diagnosed follicular lymphoma in the prerituximab era: effect of response quality on survival--A study from the groupe d'etude des lymphomes de l'adulte.

P2888

nrclinonc.2011.212

P304

72-74

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NRCLINONC.2011.212

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-01-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1019897168

http://www.w3.org/2001/XMLSchema#string

P698

22231754

http://www.w3.org/2001/XMLSchema#string